Patent Application: Benzofuranyl/Benzoxazolyl Compounds for Cancer Treatment
Summary
The USPTO has published a patent application (US20260085064A1) for substituted benzofuranyl and benzoxazolyl compounds, including their synthesis and use in treating cancer. The application was filed on May 2, 2025, by inventors from institutions including the University of Texas MD Anderson Cancer Center.
What changed
This document is a published patent application from the USPTO detailing novel substituted benzofuranyl and benzoxazolyl compounds. The application, identified as US20260085064A1, specifically describes compounds and their use in treating cancer, such as mantle cell lymphoma. The filing date for this application was May 2, 2025.
As this is a patent application, it represents a request for intellectual property protection rather than a regulatory mandate. Companies involved in pharmaceutical research and development, particularly in oncology, may find this application of interest for competitive intelligence or potential licensing opportunities. There are no immediate compliance obligations or deadlines associated with this publication for regulated entities.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF
Application US20260085064A1 Kind: A1 Mar 26, 2026
Inventors
Erkan Baloglu, Sharon Shacham, William Senapedis, Dilara McCauley, Yosef Landesman, Gali Golan, Ori Kalid, Sharon Shechter
Abstract
The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula A, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.
CPC Classifications
C07D 405/14 C07D 307/81 C07D 405/12 C07D 409/14 C07D 413/12 C07D 413/14 C07D 417/12 C07D 491/048 C07D 491/08
Filing Date
2025-05-02
Application No.
19197345
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.